Figure 1From: Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zoneModified Neurological Severity Scores (NSS). Improved NSS were shown in mice treated with TGF-β1 (n = 4) than in control groups (n = 6) after middle cerebral artery occlusion (MCAO). Data are presented as mean ± SEM. *P < 0.05 vs. control.Back to article page